The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU

Last updated: December 16, 2024
Sponsor: Children's Hospital of Fudan University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hormone Deficiencies

Treatment

serum copeptin levels

Clinical Study ID

NCT06742060
fdpicu-30
  • Ages 29-18
  • All Genders

Study Summary

Central diabetes insipidus (CDI),a disease caused by the decrease of AVP (a hormone involved in the control of water-electrolyte balance ) secretion and characerized by polyuria, is a common complication after neurosurgerical intervention and there is a lack of diagnostic criteria.Since the surgry casuses damage to patients' AVP-secreting neuronal cells, transient CDI (t-CDI) usually occurs 24-48h postoperatively and gradually resolves in about 10 days.However,permanent CDI (p-CDI) occurs in a small percentage of patients.Copeptin is a fragment of AVP, which has been shown to response the secretion of AVP.Multiple international studies have identified clinical applications for the use of copeptin to differentially diagnose adults with CDI , to assess electrolyte disturbances associated with AVP regulation, and to predict postoperative CDI after pituitary surgery.This study aims to investigate the trend of serum copeptin levels and its clinical value for postoperative CDI in pediatric patients after neurosurgerical intervention in ICU.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male and female,age ≥29 days and <18 years

  • After neurosurgical intervention

  • The patient agrees to comply with the requirements of the program, includingfollow-up visits and other related matters

Exclusion

Exclusion Criteria:

  • Structural diseases of the genitourinary system (with the possibility of nephrogenicdiabetes insipidus)

  • Preoperative symptoms of diabetes insipidus

  • Diabetes mellitus (HbA1c >8.5%)

  • Drugs causing excessive drinking and urination (e.g., sodium-glucose cotransporter-2inhibitors and diuretics)

  • Lack of follow-up data after 3 months

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: serum copeptin levels
Phase:
Study Start date:
November 22, 2024
Estimated Completion Date:
December 31, 2026

Study Description

In children and adolescents, the concentration distribution of copeptin has been gradually explored in recent years,but International studies have not yet shown the trend of copeptin levels in pediatric patients after neurosurgical intervention and its value in predicting CDI.

The primary objective of this study is to investigate the trend of serum copetin levels in ICU children after neurosurgerical intervention and compare differences of copeptide levels in children with CDI (t-CDI, p-CDI) and non-CDI. The secondary objective is to evaluate the optimal detection time and CUT OFF of copeptin in predicting the postoperative secondary CDI .

Blood sampling time points of serum copeptin levels are listed as follow:

presurgery(T0), 1h (T1), 1 day (T2), 2 days (T3), 3 days (T4), 4 days (T5), 5 day (T6) after surgury.

Connect with a study center

  • Children's Hospital of Fudan University

    Shanghai, Shanghai 201102
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.